LOW-VOLUME · HOSP-HEAVY
acebutolol Side Effects
acebutolol (also sold as Sectral) is a LOW-VOLUME FAERS extract #482 of 524 by FAERS report count. Still opens on HOSP-HEAVY: 75.5% mention hospitalization (921 reports).
Data updated 2026-05-15
- 1,220
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
acebutolol: 75.5% mention hospitalization (921 reports). Death stamp DEATH-MARKED; volume band LOW-VOLUME #482 of 524 by FAERS report count.
Thinner FAERS extract for acebutolol (Sectral) (1,220 reports #482 of 524 by FAERS report count). 75.5% mention hospitalization (921 reports). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2004–2025). Stamps SIGNAL · DEATH-MARKED · HOSP-HEAVY · FEMALE-LED.
COGNITIVE DISORDER leads 620 of 1,220 reports
FEMALE-LED reporters · age peak 75+
Female-led reporters (81% of sex-coded rows)
Age peak 75+ (726 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death appears on 44 reports (3.6% - MARKED). Reactions below co-occur in those rows only.
| Reaction | Reports |
|---|---|
| DRUG INTERACTION | 6 |
| HAEMATEMESIS | 6 |
| AGRANULOCYTOSIS | 5 |
| CEREBRAL HAEMATOMA | 5 |
| CONDITION AGGRAVATED | 4 |
| ACUTE KIDNEY INJURY | 3 |
| FALL | 3 |
| LEUKAEMIA | 3 |
| LEUKOPENIA | 3 |
| ASTHENIA | 2 |
| BLOOD CREATININE INCREASED | 2 |
| DEATH | 2 |
| DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS | 2 |
| DYSPNOEA | 2 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 2 |
| HEAD INJURY | 2 |
| HEMIPLEGIA | 2 |
| THERAPEUTIC RESPONSE SHORTENED | 2 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (921, 75.5% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| COGNITIVE DISORDER | 613 |
| FALL | 601 |
| ORTHOSTATIC HYPOTENSION | 566 |
| BALANCE DISORDER | 558 |
| CONSTIPATION | 554 |
| HYPOTENSION | 550 |
| SEDATION | 531 |
| MOBILITY DECREASED | 501 |
| DEPRESSED LEVEL OF CONSCIOUSNESS | 493 |
| SEDATION COMPLICATION | 486 |
| PAIN | 479 |
| BLOOD CALCIUM DECREASED | 478 |
| CREATININE RENAL CLEARANCE DECREASED | 478 |
| TOXICITY TO VARIOUS AGENTS | 465 |
| DYSPNOEA | 94 |
| MULTIPLE DRUG THERAPY | 93 |
| DRUG INTERACTION | 82 |
| RENAL FUNCTION TEST ABNORMAL | 60 |
How to read acebutolol FAERS figures (SIGNAL · DEATH-MARKED · HOSP-HEAVY)
FAERS holds 1,220 voluntary reports linked to acebutolol (Sectral), 2004-2025. Death is listed on 44 (3.6%). Hospitalization appears on 921 (75.5%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and FEMALE-LED skew still differ by drug; not a complete safety profile.
Read with acebutolol
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-HEAVY stamps.
ABS(total_reports) peer at 1,205 FAERS cases (Δ 15 lighter vs acebutolol); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-HEAVY · FEMALE-LED.
ABS(total_reports) peer at 1,191 FAERS cases (Δ 29 lighter vs acebutolol); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-HEAVY · FEMALE-LED.
ABS(total_reports) peer at 1,256 FAERS cases (Δ 36 heavier vs acebutolol); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's SIGNAL · DEATH-MARKED · HOSP-HEAVY · FEMALE-LED.
ABS(total_reports) peer at 1,275 FAERS cases (Δ 55 heavier vs acebutolol); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's SIGNAL · DEATH-MARKED · HOSP-HEAVY · FEMALE-LED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 58.5 pp vs acebutolol's DEATH-MARKED): CASELOAD · HOSP-MID.
acebutolol stamps DEATH-MARKED · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload SIGNAL and the label guide.